✦ LIBER ✦

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

✍ Scribed by Castañeda, Carlos A.; Gomez, Henry L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2-positive breast cancer: trastuzumab

✍ Roger Y. Tsang; Richard S. Finn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Pilot neoadjuvant trial in HER2 positive

✍ Virginia G. Kaklamani; Kalliopi Siziopikou; Denise Scholtens; Mario Lacouture; J 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 289 KB

A phase Ib study of preoperative lapatin

✍ In Hae Park, Keun Seok Lee, Han-Sung Kang, Seok Won Kim, Seeyoun Lee, So-Youn Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 158 KB

Targeting HER 1 and 2 in breast cancer w

✍ Gerald M. Higa 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 119 KB

Targeted therapy for HER2 positive breas

✍ Jason A Incorvati, Shilpan Shah, Ying Mu, Janice Lu 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 225 KB

An overview of HER-targeted therapy with

✍ Heather McArthur 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 574 KB